BRIEF-Theratechnologies to move forward with development of new single vial formulation for EGRIFTA

Wed Sep 28, 2016 10:02am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Sept 28 (Reuters) - Theratechnologies Inc

* Theratechnologies to move forward with development of new single vial formulation for EGRIFTA(R)(Tesamorelin for injection) Source text for Eikon: Further company coverage: